UPLIZNA
Google image searchProduct monograph
Active ingredient
inebilizumab, 10 MG/ML
DIN: 02543931
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE-USE
Schedule: Prescription / Schedule D
Company: HORIZON THERAPEUTICS IRELAND DAC
Date: 18-JUN-2024
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AG — Monoclonal antibodies (ATC, ATC/DDD)
- L04AG10 — INEBILIZUMAB (ATC/DDD)
